IBX vs IVX

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

IBX

IMAGIONBIO FPO [IBX]

41LOW

IVX

INVION FPO [IVX]

41LOW

Score Breakdown

IBX IVX
Technical
52
57
Catalyst
50
53
Sentiment
50
50
Fundamental
11
17
Momentum
59
54
Risk Gate
37
45

Key Metrics

IBX Metric IVX
$10.3MMarket Cap$7.3M
2.1MAvg Volume (20d)76K
N/AShort InterestN/A
$0.05552-Week High$0.200
$0.01152-Week Low$0.075
+0.0%Daily Change+0.0%
$0.019Entry Price$0.075
N/AROE-111.5%
N/AProfit MarginN/A

Active Signals

IBX Signals

●RSI drifting toward oversold territory — worth watching
●MACD just crossed bullish — momentum is shifting to the upside
●Stochastic just turned bullish from a low level — early reversal sign
●Trading below both moving averages — the trend is working against this one
●Volume surging at 2.2x normal while price falls — heavy selling pressure
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Volatility is expanding fast — choppy price action, so buckle up
●Below the 200-day average — the long-term trend is still working against it

IVX Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (0.2 quarters)
●Pre-revenue with limited cash
●Piotroski F-Score weak (2/9, low-confidence approx)

Ask Scout AI to compare IBX and IVX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IBX Full Analysis → IVX Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).